Angiogenese (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Angiogenese" in German language version.

refsWebsite
Global rank German rank
2nd place
3rd place
4th place
7th place
123rd place
6th place
274th place
152nd place
low place
1,019th place
2,112th place
1,609th place
447th place
751st place

doi.org

  • W. Risau: Mechanisms of angiogenesis. In: Nature. Band 386, Nummer 6626, April 1997, S. 671–674. ISSN 0028-0836. doi:10.1038/386671a0. PMID 9109485. (Review).
  • Vladan Milosevic, Reidunn J. Edelmann, Ingeborg Winge, Carina Strell, Artur Mezheyeuski, Gøril Knutsvik, Cecilie Askeland, Elisabeth Wik, Lars A. Akslen, Arne Östman: Vessel size as a marker of survival in estrogen receptor positive breast cancer. In: Breast Cancer Research and Treatment. Band 200, Nr. 2, Juli 2023, ISSN 0167-6806, S. 293–304, doi:10.1007/s10549-023-06974-4 (springer.com [abgerufen am 20. Januar 2024]).
  • Lars Tore Gyland Mikalsen, Hari Prasad Dhakal, Øyvind S. Bruland, Bjørn Naume, Elin Borgen, Jahn M. Nesland, Dag Rune Olsen: The Clinical Impact of Mean Vessel Size and Solidity in Breast Carcinoma Patients. In: PLOS ONE. Band 8, Nr. 10, 10. November 2013, ISSN 1932-6203, S. e75954, doi:10.1371/journal.pone.0075954, PMID 24146798, PMC 3795733 (freier Volltext) – (plos.org [abgerufen am 20. Januar 2024]).
  • Vladan Milosevic, Reidunn J. Edelmann, Ingeborg Winge, Carina Strell, Artur Mezheyeuski, Gøril Knutsvik, Cecilie Askeland, Elisabeth Wik, Lars A. Akslen, Arne Östman: Vessel size as a marker of survival in estrogen receptor positive breast cancer. In: Breast Cancer Research and Treatment. Band 200, Nr. 2, Juli 2023, ISSN 0167-6806, S. 293–304, doi:10.1007/s10549-023-06974-4 (springer.com [abgerufen am 20. Januar 2024]).
  • Barbara Klencke, Saveri Bhattacharya, Meghna Samant, Julie R. Gralow, Maura N. Dickler, Melody A. Cobleigh, Edith A. Perez, Tamara N. Shenkier, Nancy E. Davidson, Kathy D. Miller: Independent review of E2100 progression-free survival (PFS) with the addition of bevacizumab (B) to paclitaxel (P) as initial chemotherapy for metastatic breast cancer (MBC). In: Journal of Clinical Oncology. 2008, Band 26, Nummer 15_suppl, S. 1036 doi:10.1200/jco.2008.26.15_suppl.1036.

fda.gov

nih.gov

ncbi.nlm.nih.gov

  • W. Risau: Mechanisms of angiogenesis. In: Nature. Band 386, Nummer 6626, April 1997, S. 671–674. ISSN 0028-0836. doi:10.1038/386671a0. PMID 9109485. (Review).
  • Thomas H. Adair, Jean-Pierre Montani: Angiogenesis. Morgan & Claypool Life Sciences, San Rafael, CA 2010.
  • Lars Tore Gyland Mikalsen, Hari Prasad Dhakal, Øyvind S. Bruland, Bjørn Naume, Elin Borgen, Jahn M. Nesland, Dag Rune Olsen: The Clinical Impact of Mean Vessel Size and Solidity in Breast Carcinoma Patients. In: PLOS ONE. Band 8, Nr. 10, 10. November 2013, ISSN 1932-6203, S. e75954, doi:10.1371/journal.pone.0075954, PMID 24146798, PMC 3795733 (freier Volltext) – (plos.org [abgerufen am 20. Januar 2024]).
  • N. Almog: Molecular mechanisms underlying tumor dormancy. In: Cancer Lett. 294, 2010, S. 139–146. PMID 20363069
  • O. Benny, O. Fainaru, A. Adini, F. Cassiola, L. Bazinet, I. Adini, E. Pravda, Y. Nahmias, S. Koirala, G. Corfas, R. J. D’Amato, J. Folkman: An orally delivered small-molecule formulation with antiangiogenic and anticancer activity. In: Nat Biotechnol. 26(7), Jul 2008, S. 799–807. Epub 2008 Jun 29. PMID 18587385

plos.org

journals.plos.org

  • Lars Tore Gyland Mikalsen, Hari Prasad Dhakal, Øyvind S. Bruland, Bjørn Naume, Elin Borgen, Jahn M. Nesland, Dag Rune Olsen: The Clinical Impact of Mean Vessel Size and Solidity in Breast Carcinoma Patients. In: PLOS ONE. Band 8, Nr. 10, 10. November 2013, ISSN 1932-6203, S. e75954, doi:10.1371/journal.pone.0075954, PMID 24146798, PMC 3795733 (freier Volltext) – (plos.org [abgerufen am 20. Januar 2024]).

pschyrembel.de

springer.com

link.springer.com

  • Vladan Milosevic, Reidunn J. Edelmann, Ingeborg Winge, Carina Strell, Artur Mezheyeuski, Gøril Knutsvik, Cecilie Askeland, Elisabeth Wik, Lars A. Akslen, Arne Östman: Vessel size as a marker of survival in estrogen receptor positive breast cancer. In: Breast Cancer Research and Treatment. Band 200, Nr. 2, Juli 2023, ISSN 0167-6806, S. 293–304, doi:10.1007/s10549-023-06974-4 (springer.com [abgerufen am 20. Januar 2024]).
  • Vladan Milosevic, Reidunn J. Edelmann, Ingeborg Winge, Carina Strell, Artur Mezheyeuski, Gøril Knutsvik, Cecilie Askeland, Elisabeth Wik, Lars A. Akslen, Arne Östman: Vessel size as a marker of survival in estrogen receptor positive breast cancer. In: Breast Cancer Research and Treatment. Band 200, Nr. 2, Juli 2023, ISSN 0167-6806, S. 293–304, doi:10.1007/s10549-023-06974-4 (springer.com [abgerufen am 20. Januar 2024]).

zdb-katalog.de

  • W. Risau: Mechanisms of angiogenesis. In: Nature. Band 386, Nummer 6626, April 1997, S. 671–674. ISSN 0028-0836. doi:10.1038/386671a0. PMID 9109485. (Review).
  • Vladan Milosevic, Reidunn J. Edelmann, Ingeborg Winge, Carina Strell, Artur Mezheyeuski, Gøril Knutsvik, Cecilie Askeland, Elisabeth Wik, Lars A. Akslen, Arne Östman: Vessel size as a marker of survival in estrogen receptor positive breast cancer. In: Breast Cancer Research and Treatment. Band 200, Nr. 2, Juli 2023, ISSN 0167-6806, S. 293–304, doi:10.1007/s10549-023-06974-4 (springer.com [abgerufen am 20. Januar 2024]).
  • Lars Tore Gyland Mikalsen, Hari Prasad Dhakal, Øyvind S. Bruland, Bjørn Naume, Elin Borgen, Jahn M. Nesland, Dag Rune Olsen: The Clinical Impact of Mean Vessel Size and Solidity in Breast Carcinoma Patients. In: PLOS ONE. Band 8, Nr. 10, 10. November 2013, ISSN 1932-6203, S. e75954, doi:10.1371/journal.pone.0075954, PMID 24146798, PMC 3795733 (freier Volltext) – (plos.org [abgerufen am 20. Januar 2024]).
  • Vladan Milosevic, Reidunn J. Edelmann, Ingeborg Winge, Carina Strell, Artur Mezheyeuski, Gøril Knutsvik, Cecilie Askeland, Elisabeth Wik, Lars A. Akslen, Arne Östman: Vessel size as a marker of survival in estrogen receptor positive breast cancer. In: Breast Cancer Research and Treatment. Band 200, Nr. 2, Juli 2023, ISSN 0167-6806, S. 293–304, doi:10.1007/s10549-023-06974-4 (springer.com [abgerufen am 20. Januar 2024]).